Rajan R, Dovbenyuk R, Kshatriya M, Yanikomeroglu S, Banfield L, Athale U
Adolesc Health Med Ther. 2025; 15:109-117.
PMID: 40017672
PMC: 11865916.
DOI: 10.2147/AHMT.S482859.
Nguyen J, Le W, Brugger R, Shah A, Karur P, Hedelund M
Cureus. 2025; 16(12):e76343.
PMID: 39867016
PMC: 11761540.
DOI: 10.7759/cureus.76343.
Morat B, Lucidarme N, Gibert A, Harbulot C, Lachaume N, Greteau S
Front Pediatr. 2024; 11:1245861.
PMID: 38188912
PMC: 10769491.
DOI: 10.3389/fped.2023.1245861.
Seneviratne S, Kumarihamy Karunathilake C, Pallegama C, Malintha Lahiru T, Jayarajah U
Best Pract Res Clin Endocrinol Metab. 2023; 37(4):101792.
PMID: 37453832
PMC: 10303324.
DOI: 10.1016/j.beem.2023.101792.
Jaques-Albuquerque L, Dos Anjos-Martins E, Torres-Nunes L, Valerio-Penha A, Coelho-Oliveira A, da Silva Sarandy V
Diagnostics (Basel). 2023; 13(8).
PMID: 37189600
PMC: 10137815.
DOI: 10.3390/diagnostics13081499.
Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care.
Zucchini S, Scozzarella A, Maltoni G
World J Diabetes. 2023; 14(3):198-208.
PMID: 37035223
PMC: 10075036.
DOI: 10.4239/wjd.v14.i3.198.
"One and a Half Years of Things We Could Have Done": Multi-Method Analysis of the Narratives of Adolescents with Type 1 Diabetes during the COVID-19 Pandemic.
Tremolada M, Cusinato M, DAgnillo A, Negri A, Righetto E, Moretti C
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767985
PMC: 9916259.
DOI: 10.3390/ijerph20032620.
The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies.
Han Y, Chen Y, Sun C, Zhou Z
Front Endocrinol (Lausanne). 2022; 13:1069559.
PMID: 36531473
PMC: 9748149.
DOI: 10.3389/fendo.2022.1069559.
An exploratory analysis of the impact of the COVID-19 pandemic on pediatric type 1 diabetes mellitus patient outcomes: A single-center study.
Rajan R, Athale U, Ewusie J, McAssey K, Thabane L, Samaan M
Front Pediatr. 2022; 10:1038345.
PMID: 36467474
PMC: 9716184.
DOI: 10.3389/fped.2022.1038345.
Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
Kaushal T, Tinsley L, Volkening L, Turcotte C, Laffel L
J Clin Endocrinol Metab. 2022; 107(10):e4197-e4202.
PMID: 35948357
PMC: 9516076.
DOI: 10.1210/clinem/dgac476.
The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
Hakonen E, Varimo T, Tuomaala A, Miettinen P, Pulkkinen M
BMC Pediatr. 2022; 22(1):48.
PMID: 35045807
PMC: 8766349.
DOI: 10.1186/s12887-022-03115-6.
Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes.
Lazzeroni P, Motta M, Monaco S, Laudisio S, Furoncoli D, Maffini V
Acta Biomed. 2021; 92(5):e2021399.
PMID: 34738562
PMC: 8689301.
DOI: 10.23750/abm.v92i5.11911.
Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review.
Eberle C, Stichling S
Diabetol Metab Syndr. 2021; 13(1):95.
PMID: 34493317
PMC: 8423337.
DOI: 10.1186/s13098-021-00705-9.
